BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 12885818)

  • 1. Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review.
    Lopez JL; Pérez C; Marquez C; Cabrera P; Perez JM; Ramirez GL; Ordoñez R; Praena-Fernandez JM; Ortiz MJ
    Rep Pract Oncol Radiother; 2011 May; 16(5):163-9. PubMed ID: 24376974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious Morbidity in Pediatric Patients Receiving Neoadjuvant Chemotherapy for Sarcoma.
    Willmer D; Zöllner SK; Schaumburg F; Jürgens H; Lehrnbecher T; Groll AH
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas.
    Castillo-Ecija H; Pascual-Pasto G; Perez-Jaume S; Resa-Pares C; Vila-Ubach M; Monterrubio C; Jimenez-Cabaco A; Baulenas-Farres M; Muñoz-Aznar O; Salvador N; Cuadrado-Vilanova M; Olaciregui NG; Balaguer-Lluna L; Burgueño V; Vicario FJ; Manzanares A; Castañeda A; Santa-Maria V; Cruz O; Celis V; Morales La Madrid A; Garraus M; Gorostegui M; Vancells M; Carrasco R; Krauel L; Torner F; Suñol M; Lavarino C; Mora J; Carcaboso AM
    J Pathol Clin Res; 2021 Jul; 7(4):338-349. PubMed ID: 33837665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.
    Dirksen U; Brennan B; Le Deley MC; Cozic N; van den Berg H; Bhadri V; Brichard B; Claude L; Craft A; Amler S; Gaspar N; Gelderblom H; Goldsby R; Gorlick R; Grier HE; Guinbretiere JM; Hauser P; Hjorth L; Janeway K; Juergens H; Judson I; Krailo M; Kruseova J; Kuehne T; Ladenstein R; Lervat C; Lessnick SL; Lewis I; Linassier C; Marec-Berard P; Marina N; Morland B; Pacquement H; Paulussen M; Randall RL; Ranft A; Le Teuff G; Wheatley K; Whelan J; Womer R; Oberlin O; Hawkins DS;
    J Clin Oncol; 2019 Dec; 37(34):3192-3202. PubMed ID: 31553693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ewing's sarcoma of the cervix: A case report of an unusual diagnosis in pregnancy treated with surgery, adjuvant VIDE and radiotherapy.
    Kyriazoglou A; Tsironis G; Liontos M; Papakosta A; Mahaira L; Thomakos N; Morphopoulos G; Papaspyrou I; Bamias A
    Oncol Lett; 2019 Jun; 17(6):5529-5535. PubMed ID: 31186774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.
    Whelan J; Le Deley MC; Dirksen U; Le Teuff G; Brennan B; Gaspar N; Hawkins DS; Amler S; Bauer S; Bielack S; Blay JY; Burdach S; Castex MP; Dilloo D; Eggert A; Gelderblom H; Gentet JC; Hartmann W; Hassenpflug WA; Hjorth L; Jimenez M; Klingebiel T; Kontny U; Kruseova J; Ladenstein R; Laurence V; Lervat C; Marec-Berard P; Marreaud S; Michon J; Morland B; Paulussen M; Ranft A; Reichardt P; van den Berg H; Wheatley K; Judson I; Lewis I; Craft A; Juergens H; Oberlin O;
    J Clin Oncol; 2018 Sep; 36(31):JCO2018782516. PubMed ID: 30188789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of Ewing sarcoma family of tumors: recent developments in systemic therapy.
    Owens C; Abbott LS; Gupta AA
    Paediatr Drugs; 2013 Dec; 15(6):473-92. PubMed ID: 23760780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas.
    Whelan J; Khan A; Sharma A; Rothermundt C; Dileo P; Michelagnoli M; Seddon B; Strausss S
    Clin Sarcoma Res; 2012 Sep; 2(1):12. PubMed ID: 22998944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteomalacia as a late metabolic complication of Ifosfamide chemotherapy in young adults: illustrative cases and review of the literature.
    Church DN; Hassan AB; Harper SJ; Wakeley CJ; Price CG
    Sarcoma; 2007; 2007():91586. PubMed ID: 17641745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution.
    McTiernan AM; Cassoni AM; Driver D; Michelagnoli MP; Kilby AM; Whelan JS
    Sarcoma; 2006; 2006():83548. PubMed ID: 17496997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma.
    Engelhardt M; Zeiser R; Ihorst G; Finke J; Müller CI
    J Cancer Res Clin Oncol; 2007 Jan; 133(1):1-11. PubMed ID: 16835746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
    Wexler LH; DeLaney TF; Tsokos M; Avila N; Steinberg SM; Weaver-McClure L; Jacobson J; Jarosinski P; Hijazi YM; Balis FM; Horowitz ME
    Cancer; 1996 Aug; 78(4):901-11. PubMed ID: 8756388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.
    Snijders-Keilholz A; Ewing P; Seynaeve C; Burger CW
    Gynecol Oncol; 2005 Sep; 98(3):516-9. PubMed ID: 15979131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents.
    Lerro KA; Medoff E; Wu Y; Seropian SE; Snyder E; Krause D; Cooper DL
    Bone Marrow Transplant; 2003 Dec; 32(12):1113-7. PubMed ID: 14647264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.
    Strauss SJ; McTiernan A; Driver D; Hall-Craggs M; Sandison A; Cassoni AM; Kilby A; Michelagnoli M; Pringle J; Cobb J; Briggs T; Cannon S; Witt J; Whelan JS
    J Clin Oncol; 2003 Aug; 21(15):2974-81. PubMed ID: 12885818
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.